Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2017-08-22
2030-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors
NCT02665494
Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars
NCT06375941
Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
NCT02547831
An Observational Study of Local Relapse After High Grade Osteosarcoma
NCT06017518
Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.
NCT05690412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epitheloid Sarcoma patients
Patients with diagnosis of localized or advanced epitheloid sarcoma seen in the Italian reference centers for sarcoma treatment that receive treatment for Epitheloid Sarcoma
Treatment for Epitheloid Sarcoma
Treatment Epitheloid Sarcoma according the disease guideline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment for Epitheloid Sarcoma
Treatment Epitheloid Sarcoma according the disease guideline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Signed informed consent
3. Adequate patient compliance to treatment or follow up
4. No age limit
Exclusion Criteria
2. Impossibility to ensure adequate compliance
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Italian Sarcoma Group
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paolo Casali, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione IRCCS INT Milano
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST
Meldola, FC, Italy
Istituto Europeo di Oncologia
Milan, MI, Italy
Istituto Clinico Humanitas
Rozzano, MI, Italy
Azienda Ospedaliera Universitaria Paolo Giaccone
Palermo, PA, Italy
Fondazione del Piemonte per l'Oncologia IRCC Candiolo
Candiolo, Torino, Italy
Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors
Bologna, , Italy
Fondazione IRCCS INT Milano
Milan, , Italy
Irccs Istituto Oncologico Veneto (Iov)
Padua, , Italy
Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4
Prato, , Italy
Campus Biomedico
Roma, , Italy
Istituti Fisioterapici Ospitalieri di Roma
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lorella Gurreri, MD
Role: primary
Antonella Brunello, MD
Role: primary
Bruno Vincenzi, MD
Role: primary
Virginia Ferraresi, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Thway K, Jones RL, Noujaim J, Fisher C. Epithelioid Sarcoma: Diagnostic Features and Genetics. Adv Anat Pathol. 2016 Jan;23(1):41-9. doi: 10.1097/PAP.0000000000000102.
Guillou L, Wadden C, Coindre JM, Krausz T, Fletcher CD. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol. 1997 Feb;21(2):130-46. doi: 10.1097/00000478-199702000-00002.
Chase DR, Enzinger FM. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment. Am J Surg Pathol. 1985 Apr;9(4):241-63.
Bos GD, Pritchard DJ, Reiman HM, Dobyns JH, Ilstrup DM, Landon GC. Epithelioid sarcoma. An analysis of fifty-one cases. J Bone Joint Surg Am. 1988 Jul;70(6):862-70.
Halling AC, Wollan PC, Pritchard DJ, Vlasak R, Nascimento AG. Epithelioid sarcoma: a clinicopathologic review of 55 cases. Mayo Clin Proc. 1996 Jul;71(7):636-42. doi: 10.1016/S0025-6196(11)63000-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISG-EPISObs
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.